Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate

Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate

US Patent 8551987 · Granted Oct 8, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R2024
Crystalline salts of a B-RAF kinase inhibitor2023
Crystalline salts of a B-RAF kinase inhibitor2022
(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R2021
Medical use of compound III2021
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD an2020
(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-y1)(5-methyl-6-(((2R2020
(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R2019
Stereoselective process2019
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD an2017
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2017
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2017